May 30, 2014 — The U.S. Food and Drug Administration (FDA) granted market clearance to the CardioMEMS Heart Failure ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).

May 23, 2014 — Medtronic announced the results from the first prospective randomized clinical trial to show that ...

May 22, 2014 — A study presented at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions ...
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
May 22, 2014 — Hospira Inc. issued a nationwide recall to the user level for one lot of Dobutamine Injection, USP, 250 ...
May 7, 2014 — HeartWare Intl. Inc. issued a voluntary Urgent Medical Device Correction related to all HeartWare ...
April 30, 2014 — Celladon Corp. announced its lead product candidate, Mydicar, has been granted breakthrough therapy ...

April 28, 2014 — An Arizona State University research group and medical professionals at Phoenix Children’s Hospital are ...

April 25, 2014 — Vanderbilt Heart and Vascular Institute (VHVI) was the first facility in Tennessee to implant the ...
April 24, 2014 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval for its latest ...
April 23, 2014 — The PROCEED II heart transplant U.S. Food and Drug Administration (FDA) pivotal trial results using the ...
April 21, 2014 — Decision Resources Group announced in a report that Servier's ivabradine (procoralan) is set to become ...

April 18, 2014 — Cytori Therapeutics announced publication of safety and efficacy data from a 36 month European clinical ...
April 18, 2014 — New research presented at the 34th annual meeting of the International Society for Heart and Lung ...
April 17, 2014 — Medtronic announced the U.S. Food and Drug Administration (FDA) approved an expanded indication for ...
April 10, 2014 — CardioKinetix Inc. announced results of a pooled analysis study of the catheter-based Parachute ...